AstraZeneca India gets CDSCO approval for additional indication for Osimertinib in unresectable EGFR-mutated lung cancer Read more
China’s biopharma commands $30 billion in oncology licensing deals, triples US output in 2024 Read more
Vgenomics, Dr. Shroff Charity Eye Hospital partner to validate biomarker for early Keratoconus detection Read more
Zydus Lifesciences’ provides an update on its campaign from promoting breast cancer awareness Read more
Lupin announces presentation of phase 1 data on LNP7457 (PRMT5 inhibitor) at the ASCO – Annual Meeting 2025 Read more